95 related articles for article (PubMed ID: 10730080)
1. An effective method for recovering CD34 positive progenitor cells from peripheral blood stem cell apheresis products cryopreserved with simplified method.
Ohta K; Yamane T; Koh KR; Ohta T; Nakamae H; Takubo T; Hino M; Tatsumi N
Osaka City Med J; 1999 Dec; 45(2):139-48. PubMed ID: 10730080
[TBL] [Abstract][Full Text] [Related]
2. Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres.
Koizumi K; Nishio M; Endo T; Takashima H; Haseyama Y; Fujimoto K; Yamamoto S; Sato N; Ikebuchi K; Ikeda H; Koike T; Sawada K
Bone Marrow Transplant; 2000 Oct; 26(7):787-93. PubMed ID: 11042662
[TBL] [Abstract][Full Text] [Related]
3. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
4. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
5. Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells.
Gutensohn K; Nikolitsis A; Gramatzki M; Spitzer D; Buwitt-Beckmann U; Humpe A
Transfus Med; 2012 Jun; 22(3):205-10. PubMed ID: 22519551
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes.
Cassens U; Barth IM; Baumann C; Fischer RJ; Kienast J; Vormoor J; Sibrowski W
Transfusion; 2004 Nov; 44(11):1593-602. PubMed ID: 15504165
[TBL] [Abstract][Full Text] [Related]
7. Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining.
Humpe A; Beck C; Schoch R; Kneba M; Horst HA
Transfusion; 2005 Jul; 45(7):1208-13. PubMed ID: 15987368
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
[TBL] [Abstract][Full Text] [Related]
9. Two CD34+ stem cells from umbilical cord blood enrichment methods.
Pafumi C; Bosco P; Cavallaro A; Farina M; Leonardi I; Pernicone G; Bandiera S; Russo A; Giardina P; Chiarenza M; Calogero AE
Pediatr Hematol Oncol; 2002 Jun; 19(4):239-45. PubMed ID: 12051590
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
[TBL] [Abstract][Full Text] [Related]
11. Immature granulocyte fraction in the peripheral blood is a practical indicator for mobilization of CD34(+) cells.
Endo-Matsubara M; Ogawa S; Sasaki K; Takahashi T; Chiba S; Hirai H
Am J Hematol; 2004 Nov; 77(3):223-8. PubMed ID: 15495256
[TBL] [Abstract][Full Text] [Related]
12. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
13. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
Bojko P; Scharifi M; Stössel K; Seeber S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
[TBL] [Abstract][Full Text] [Related]
14. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries.
Takahashi TA; Rebulla P; Armitage S; van Beckhoven J; Eichler H; Kekomäki R; Letowska M; Wahab F; Moroff G
Cytotherapy; 2006; 8(3):254-64. PubMed ID: 16793734
[TBL] [Abstract][Full Text] [Related]
15. Management strategies for poor peripheral blood stem cell mobilization.
Moog R
Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
[TBL] [Abstract][Full Text] [Related]
16. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: comparison by a randomized crossover study.
Ikeda K; Ohto H; Kanno T; Ogata T; Noji H; Ogawa K; Maruyama Y
Transfusion; 2007 Jul; 47(7):1234-40. PubMed ID: 17581158
[TBL] [Abstract][Full Text] [Related]
17. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
18. [Successful hematologic reconstitution using CD34+ cells positively selected from cryopreserved autologous peripheral blood stem cells in a patient with malignant lymphoma].
Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T
Rinsho Ketsueki; 2000 Aug; 41(8):681-6. PubMed ID: 11020998
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
Yanovich S; Mitsky P; Cornetta K; Maziarz RT; Rosenfeld C; Krause DS; Lotz JP; Bitran JD; Williams S; Preti R; Somlo G; Burtness B; Mills B
Bone Marrow Transplant; 2000 Jun; 25(11):1165-74. PubMed ID: 10849529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
